These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 21876507

  • 1. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
    Szczepankiewicz A, Rybakowski JK, Suwalska A, Hauser J.
    Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
    [Abstract] [Full Text] [Related]

  • 2. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A, Skibinska M, Suwalska A, Hauser J, Rybakowski JK.
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [Abstract] [Full Text] [Related]

  • 3. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
    Masui T, Hashimoto R, Kusumi I, Suzuki K, Tanaka T, Nakagawa S, Suzuki T, Iwata N, Ozaki N, Kato T, Kunugi H, Koyama T.
    Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. No association between the PREP gene and lithium responsive bipolar disorder.
    Mamdani F, Sequeira A, Alda M, Grof P, Rouleau G, Turecki G.
    BMC Psychiatry; 2007 Feb 26; 7():9. PubMed ID: 17324276
    [Abstract] [Full Text] [Related]

  • 9. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, Czerski PM, Hauser J.
    World J Biol Psychiatry; 2006 Feb 26; 7(3):158-61. PubMed ID: 16861141
    [Abstract] [Full Text] [Related]

  • 10. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Słopień A, Czerski PM, Leszczyńska-Rodziewicz A, Hauser J.
    Pharmacol Rep; 2005 Feb 26; 57(6):761-5. PubMed ID: 16382194
    [Abstract] [Full Text] [Related]

  • 11. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A, Chłopocka-Woźniak M, Rybakowski J.
    Psychiatr Pol; 2002 Feb 26; 36(6 Suppl):63-9. PubMed ID: 12647423
    [Abstract] [Full Text] [Related]

  • 12. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
    Masui T, Hashimoto R, Kusumi I, Suzuki K, Tanaka T, Nakagawa S, Suzuki T, Iwata N, Ozaki N, Kato T, Takeda M, Kunugi H, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):204-8. PubMed ID: 17822820
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK, Dmitrzak-Weglar M, Kliwicki S, Hauser J.
    Bipolar Disord; 2014 Mar 01; 16(2):151-8. PubMed ID: 24636202
    [Abstract] [Full Text] [Related]

  • 14. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.
    Washizuka S, Ikeda A, Kato N, Kato T.
    Int J Neuropsychopharmacol; 2003 Dec 01; 6(4):421-4. PubMed ID: 14604458
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population.
    Ceulemans S, De Zutter S, Heyrman L, Norrback KF, Nordin A, Nilsson LG, Adolfsson R, Del-Favero J, Claes S.
    Bipolar Disord; 2011 Dec 01; 13(7-8):614-23. PubMed ID: 22085474
    [Abstract] [Full Text] [Related]

  • 16. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
    Rybakowski JK, Skibinska M, Suwalska A, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J.
    Hum Psychopharmacol; 2011 Mar 01; 26(2):168-71. PubMed ID: 21437990
    [Abstract] [Full Text] [Related]

  • 17. FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
    Szczepankiewicz A, Leszczyńska-Rodziewicz A, Pawlak J, Narozna B, Rajewska-Rager A, Wilkosc M, Zaremba D, Maciukiewicz M, Twarowska-Hauser J.
    J Affect Disord; 2014 Aug 01; 164():33-7. PubMed ID: 24856550
    [Abstract] [Full Text] [Related]

  • 18. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
    Mitjans M, Arias B, Jiménez E, Goikolea JM, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Vieta E, Benabarre A.
    J Clin Psychopharmacol; 2015 Oct 01; 35(5):600-4. PubMed ID: 26267417
    [Abstract] [Full Text] [Related]

  • 19. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF, Huang MC, Liu HC.
    J Affect Disord; 2013 May 01; 147(1-3):401-6. PubMed ID: 23021822
    [Abstract] [Full Text] [Related]

  • 20. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
    Rybakowski JK, Czerski P, Dmitrzak-Weglarz M, Kliwicki S, Leszczynska-Rodziewicz A, Permoda-Osip A, Skibinska M, Suwalska A, Szczepankiewicz A, Hauser J.
    J Psychopharmacol; 2012 Mar 01; 26(3):368-73. PubMed ID: 21890592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.